Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries

FG. Rebitschek, N. Pashayan, M. Widschwendter, O. Wegwarth,

. 2019 ; 14 (6) : e0218188. [pub] 20190612

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
Department of Health - United Kingdom

BACKGROUND: Personal cancer risk assessments enable stratified care, for example, offering preventive surgical measures such as risk-reducing mastectomy (RRM) to women at high risk for breast cancer. In scenario-based experiments, we investigated whether different benefit-harm ratios of RRM influence women's consideration of this, whether this consideration is influenced by women's perception of and desire to know their personal cancer risk, or by their intention to take a novel cancer risk-predictive test, and whether consideration varies across different countries. METHOD: In January 2017, 1,675 women 40 to 75 years of age from five European countries-Czech Republic, Germany, UK, Italy, and Sweden-took part in an online scenario-based experiment. Six different scenarios of hypothetical benefit-harm ratios of RRM were presented in accessible fact box formats: Baseline risk/risk reduction pairings were 20/16, 20/4, 10/8, 10/2, 5/4, and 5/1 out of 1,000 women dying from breast cancer. RESULTS: Varying the baseline risk of dying from breast cancer and the extent of risk reduction influenced the decision to consider RRM for 23% of women. Decisions varied by country, risk perception, and the intention to take a cancer risk-predictive test. Women who expressed a stronger intention to take such a test were more likely to consider having RRM. The desire to know one's risk of developing any female cancer in general moderated women's decisions, whereas the specific desire to know the risk of breast cancer did not. CONCLUSIONS: In this hypothetical scenario-based study, only for a minority of women did the change in benefit-harm ratio inform their consideration of RRM. Because this consideration is influenced by risk perception and the intention to learn one's cancer risks via a cancer risk-predictive test, careful disclosure of different potential preventive measures and their benefit-harm ratios is necessary before testing for individual risk. Furthermore, information on risk testing should acknowledge country-specific sensitivities for benefit-harm ratios.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20015874
003      
CZ-PrNML
005      
20201119104858.0
007      
ta
008      
201012s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0218188 $2 doi
035    __
$a (PubMed)31188874
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rebitschek, Felix G $u Harding Center for Risk Literacy, Max Planck Institute for Human Development, Berlin, Germany.
245    10
$a Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries / $c FG. Rebitschek, N. Pashayan, M. Widschwendter, O. Wegwarth,
520    9_
$a BACKGROUND: Personal cancer risk assessments enable stratified care, for example, offering preventive surgical measures such as risk-reducing mastectomy (RRM) to women at high risk for breast cancer. In scenario-based experiments, we investigated whether different benefit-harm ratios of RRM influence women's consideration of this, whether this consideration is influenced by women's perception of and desire to know their personal cancer risk, or by their intention to take a novel cancer risk-predictive test, and whether consideration varies across different countries. METHOD: In January 2017, 1,675 women 40 to 75 years of age from five European countries-Czech Republic, Germany, UK, Italy, and Sweden-took part in an online scenario-based experiment. Six different scenarios of hypothetical benefit-harm ratios of RRM were presented in accessible fact box formats: Baseline risk/risk reduction pairings were 20/16, 20/4, 10/8, 10/2, 5/4, and 5/1 out of 1,000 women dying from breast cancer. RESULTS: Varying the baseline risk of dying from breast cancer and the extent of risk reduction influenced the decision to consider RRM for 23% of women. Decisions varied by country, risk perception, and the intention to take a cancer risk-predictive test. Women who expressed a stronger intention to take such a test were more likely to consider having RRM. The desire to know one's risk of developing any female cancer in general moderated women's decisions, whereas the specific desire to know the risk of breast cancer did not. CONCLUSIONS: In this hypothetical scenario-based study, only for a minority of women did the change in benefit-harm ratio inform their consideration of RRM. Because this consideration is influenced by risk perception and the intention to learn one's cancer risks via a cancer risk-predictive test, careful disclosure of different potential preventive measures and their benefit-harm ratios is necessary before testing for individual risk. Furthermore, information on risk testing should acknowledge country-specific sensitivities for benefit-harm ratios.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a nádory prsu $x genetika $x patologie $x psychologie $x chirurgie $7 D001943
650    12
$a rozhodování $7 D003657
650    _2
$a ženské pohlaví $7 D005260
650    12
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    12
$a úmysl $7 D033182
650    _2
$a mastektomie $x psychologie $7 D008408
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a riziko $7 D012306
650    _2
$a chování snižující riziko $7 D040242
650    _2
$a průzkumy a dotazníky $7 D011795
651    _2
$a Česká republika $7 D018153
651    _2
$a Německo $7 D005858
651    _2
$a Itálie $7 D007558
651    _2
$a Švédsko $7 D013548
651    _2
$a Spojené království $7 D006113
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pashayan, Nora $u Department of Applied Health Research, University College London, London, United Kingdom.
700    1_
$a Widschwendter, Martin $u Department of Women's Cancer, University College London, London, United Kingdom.
700    1_
$a Wegwarth, Odette $u Harding Center for Risk Literacy, Max Planck Institute for Human Development, Berlin, Germany. Center for Adaptive Rationality, Max Planck Institute for Human Development, Berlin, Germany.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 14, č. 6 (2019), s. e0218188
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31188874 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201012 $b ABA008
991    __
$a 20201119104855 $b ABA008
999    __
$a ok $b bmc $g 1584301 $s 1106042
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 14 $c 6 $d e0218188 $e 20190612 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
GRA    __
$p Department of Health $2 United Kingdom
LZP    __
$a Pubmed-20201012

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...